|
2025
|
P/S
|
Pharmaceutical preparations for treatment of cardiovascular
and pulmonary diseases. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases Providing ... |
|
|
P/S
|
Pharmaceuticals preparations for the treatment of cardiovascular and pulmonary diseases |
|
|
Invention
|
Injectable pharmaceutical composition for treating pulmonary hypertension. The present invention ... |
|
2024
|
P/S
|
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune... |
|
|
Invention
|
Pharmaceutical composition comprising a diphenylpyrazine derivative. The present invention relate... |
|
|
Invention
|
Pharmaceutical composition comprising a diphenylpyrazine derivative.
The present invention relat... |
|
|
Invention
|
Pharmaceutical combination comprising a selective s1p1 receptor agonist.
The present invention r... |
|
2023
|
P/S
|
Pharmaceutical preparations, excluding pharmaceutical preparations in relation to blood circulati... |
|
|
Invention
|
In vitro dissolution test. The present invention relates to testing samples comprising calcium;{4... |
|
|
Invention
|
Pyrazolopyrrolopyridazines and their uses as pdgfr inhibitors. The disclosure is directed to comp... |
|
|
Invention
|
Combination of macitentan and tadalafil for the treatment of pulmonary arterial hypertension. The... |
|
|
Invention
|
Methods and compositions for detecting or aiding diagnosis of pulmonary hypertension. Biomarkers ... |
|
|
Invention
|
Injectable pharmaceutical composition comprising a diphenylpyrazine derivative. The present inven... |
|
|
Invention
|
Triazolopyridine and benzoisoxazole carboxamides and their uses as pdgfr inhibitors. The disclosu... |
|
|
Invention
|
Pyrrolopyridine carboxamides and their uses as pdgfr inhibitors. The disclosure is directed to co... |
|
|
Invention
|
Pyrazolothiazole carboxamides and their uses as pdgfr inhibitors. The disclosure is directed to c... |
|
|
Invention
|
Pyrazolopyrazine carboxamides and their uses as pdgfr inhibitors. The disclosure is directed to c... |
|
|
Invention
|
Diphenylpyrazine compounds as prodrugs. The present invention relates to a pharmaceutical composi... |
|
|
Invention
|
Methods of slowing an increase in brain ventricular volume. The disclosure relates to methods of ... |
|
|
Invention
|
Controlled release compositions. The present disclosure related to a pharmaceutical formulation c... |
|
2022
|
Invention
|
Dispersible tablet for oral administration.
The present invention is directed to pharmaceutical ... |
|
|
Invention
|
Methods for treating multiple sclerosis. The disclosure relates to methods of preserving myelinat... |
|
|
Invention
|
Methods and compositions for predictive outcomes for pulmonary arterial hypertension treatment. B... |
|
|
Invention
|
Methods of treating multiple sclerosis. The disclosure relates to methods of treating multiple sc... |
|
|
Invention
|
Pharmaceutical composition for the treatment of pulmonary arterial hypertension.
The present inv... |
|
|
Invention
|
Bmp9 variant polypeptides and uses thereof. Isolated BMP9 and pro-BMP9 mutant polypeptides are de... |
|
|
Invention
|
Pyrazolopyrimidines and their uses as pdgfr inhibitors.
The disclosure is directed to compounds ... |
|
|
Invention
|
Pyrazolopyrimidines and their uses as pdgfr inhibitors. The disclosure is directed to compounds o... |
|
|
Invention
|
Dispersible tablet for oral administration. The present invention is directed to pharmaceutical c... |
|
|
Invention
|
Methods of treating pulmonary hypertension. This invention relates to methods of treating pulmona... |
|
|
Invention
|
Pharmaceutical composition comprising macitentan for the treatment of chronic thromboembolic pulm... |
|
|
P/S
|
Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardi... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceuticals preparations for the treatment of cardiovascular and... |
|
|
Invention
|
Pharmaceutical dosage system. A pharmaceutical dosage system includes a blister pack and a plural... |
|
|
P/S
|
Educational services, namely, providing podcasts in the field of pulmonary hypertension Providing... |
|
|
P/S
|
Human pharmaceuticals for treatment of pulmonary arterial hypertension Providing information in t... |
|
|
Invention
|
Methods for treating pulmonary hypertension in patients with left ventricular assist device impla... |
|
|
Invention
|
Process for manufacturing a diphenylphrazine derivative.
The present invention relates to a proc... |
|
|
Invention
|
Process for manufacturing a diphenylpyrazine derivative. The present invention relates to a proce... |
|
2021
|
Invention
|
Pyrazolothiazole carboxamides and their uses as pdgfr inhibitors.
The disclosure is directed to ... |
|
|
Invention
|
Selexipag for use via intracolonic administration. The present disclosure provides methods for tr... |
|
|
P/S
|
Educational services in the field of healthcare; arranging and conducting seminars, workshops, ed... |
|
|
P/S
|
Providing medical information regarding pharmaceutical products and healthcare to healthcare prof... |
|
|
Invention
|
Methods of treating and assessing pulmonary arterial hypertension with selexipag.
The present di... |
|
|
Invention
|
Controlled release selexipag composition.
The present invention is concerned with controlled rel... |
|
2020
|
Invention
|
Methods of treating pulmonary arterial hypertension.
The disclosure relates to methods of reduci... |
|
|
Invention
|
Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunc... |
|
|
Invention
|
Pharmaceutical composition comprising selexipag.
The present invention relates to pharmaceutical... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceu... |
|
|
P/S
|
Downloadable software in the nature of an application; Mobile application software; Tablet applic... |
|
|
Invention
|
Methods for treating pulmonary arterial hypertension.
The present disclosure provides methods of... |
|
|
Invention
|
Transitioning patients treated for pulmonary arterial hypertension to selexipag. The present disc... |
|
|
Invention
|
Methods for treating sarcoidosis-associated pulmonary hypertension.
The present disclosure provi... |
|
|
Invention
|
Macitentan for use in treating portopulmonary hypertension.
The present invention provides metho... |
|
|
P/S
|
Mobile application software for training medical practitioners in the detection of signs of pulmo... |
|
|
P/S
|
Application software, namely, downloadable software for receiving, collecting, displaying, transm... |
|
2019
|
P/S
|
Application software. Database management; Computer data processing; data file administration. Sa... |
|
|
P/S
|
Recorded computer application software for receiving, collecting, displaying, transmitting, proce... |
|
|
P/S
|
Downloadable computer application software for use in real-world evidence generation to facilitat... |
|
|
P/S
|
Mobile applications; mobile application software. Medical devices. Educational services. Medical ... |
|
|
P/S
|
Mobile applications; mobile application software; all of the aforementioned goods in the field of... |
|
2018
|
P/S
|
Printed matter, namely, brochures, booklets, flyers, paper signs, manuals, informational sheets a... |
|
|
P/S
|
Human pharmaceuticals for treatment of pulmonary arterial hypertension. |
|
|
P/S
|
Human pharmaceuticals for treatment of pulmonary arterial hypertension |
|
2017
|
P/S
|
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, pulmonary diseases... |
